| Developmentally regulated signaling pathways in glioma invasion S Mehta, C Lo Cascio Cellular and molecular life sciences 75, 385-402, 2018 | 81 | 2018 |
| Post-translational modifications of OLIG2 regulate glioma invasion through the TGF-β pathway SK Singh, R Fiorelli, R Kupp, S Rajan, E Szeto, CL Cascio, CL Maire, ... Cell reports 16 (4), 950-966, 2016 | 60 | 2016 |
| Investigating the Interactions of Glioma Stem Cells in the Perivascular Niche at Single‐Cell Resolution using a Microfluidic Tumor Microenvironment Model EA Adjei‐Sowah, SA O'Connor, J Veldhuizen, C Lo Cascio, C Plaisier, ... Advanced Science 9 (21), 2201436, 2022 | 15 | 2022 |
| Nonredundant, isoform-specific roles of HDAC1 in glioma stem cells CL Cascio, JB McNamara, EL Melendez, EM Lewis, ME Dufault, N Sanai, ... JCI insight 6 (17), 2021 | 11 | 2021 |
| Quisinostat is a brain-penetrant radiosensitizer in glioblastoma CL Cascio, T Margaryan, E Luna-Melendez, JB McNamara, CI White, ... JCI insight 8 (22), 2023 | 1 | 2023 |
| 505MO A phase 0/Ib study of AZD1390 plus radiotherapy in recurrent glioblastoma patients N Sanai, S Desai, T Margaryan, CL Cascio, M Elliott, J Molloy, J Harmon, ... Annals of Oncology 34, S394, 2023 | 1 | 2023 |
| STEM-25. HDAC1 IS ESSENTIAL FOR GLIOMA STEM CELL SURVIVAL CL Cascio, J McNamara, EL Melendez, S Mehta Neuro-Oncology 21 (Suppl 6), vi239, 2019 | 1 | 2019 |
| Abstract CT044: A phase 0/1b study of AZD1390 plus radiotherapy in newly-diagnosed, MGMT-unmethylated glioblastoma patients N Sanai, S Desai, T Margaryan, J Molloy, C LoCascio, M Elliott, J Harmon, ... Cancer Research 84 (7_Supplement), CT044-CT044, 2024 | | 2024 |
| A novel transcriptional complex of OLIG2-STAT5 mediates glioma stem cell self renewal and invasion A Miller, C Lo Cascio, M Blomquist, JB McNamara, K Orndorff, M Dufault, ... Cancer Research 84 (6_Supplement), 256-256, 2024 | | 2024 |
| Acute and long-term responses to treatment with the HDAC inhibitor quisinostat in preclinical models of glioblastoma K Orndorff, J McNamara, M Stavnichuk, CL Cascio, C White, EL Melendez, ... Cancer Research 84 (6_Supplement), 3222-3222, 2024 | | 2024 |
| STAT5-OLIG2 TRANSCRIPTIONAL COMPLEX MEDIATES GLIOMA STEM CELL SELF RENEWAL AND INVASION A Miller, C Lo Cascio, M Blomquist, J McNamara, K Orndorff, M Dufault, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| NOVEL, QUIESCENT SUBPOPULATION EMERGES AFTER LOW-DOSE IRRADIATION OF GLIOMA STEM CELLS E Lewis, C Lo Cascio, J McNamara, S Mehta, C Plaisier NEURO-ONCOLOGY 25, 2023 | | 2023 |
| EXTH-50. ACUTE AND LONG-TERM RESPONSES TO QUISINOSTAT TREATMENT IN PDX MODELS OF GLIOBLASTOMA K Orndorff, J McNamara, C LoCascio, C White, M Stavnichuk, K Shaik, ... Neuro-Oncology 25 (Supplement_5), v235-v235, 2023 | | 2023 |
| EXTH-30. PHARMACOKINETICS-AND PHARMACODYNAMICS-BASED EVALUATION OF QUISINOSTAT AS A RADIOSENSITIZER IN PRECLINICAL MODELS OF GBM CL Cascio, T Margaryan, EL Melendez, J McNamara, W Knight, C White, ... Neuro-Oncology 24 (Supplement_7), vii216-vii216, 2022 | | 2022 |
| Pharmacokinetics-and pharmacodynamics-based evaluation of quisinostat as a radiosensitizer in preclinical models of human glioblastoma CL Cascio, T Margaryan, EL Melendez, J McNamara, W Knight, S Himes, ... Cancer Research 82 (12_Supplement), 349-349, 2022 | | 2022 |
| In Pursuit of Specificity: Therapeutic Targeting of HDAC1 in Glioblastoma C Lo Cascio Arizona State University, 2022 | | 2022 |
| EXTH-24. TUMOR PHARMACOKINETICS, PHARMACODYNAMICS AND RADIATION SENSITIZATION IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE SECOND-GENERATION HDAC … C Lo Cascio, T Margaryan, EL Melendez, J McNamara, W Knight, ... Neuro-Oncology 23 (Supplement_6), vi168-vi168, 2021 | | 2021 |
| NON-REDUNDANT, ISOFORM-SPECIFIC ROLES OF HDAC1 IN THE REGULATION OF THE GLIOMA STEM CELL PHENOTYPE C Lo Cascio, J McNamara, EL Melendez, E Lewis, M Dufault, N Sanai, ... NEURO-ONCOLOGY 23, 25-25, 2021 | | 2021 |
| STEM-15. RADIATION-INDUCED MODULATION OF NEURODEVELOPMENTAL PATHWAYS IN CLASSICAL GLIOMA STEM CELLS CL Cascio, EL Melendez, J McNamara, R Schultz, AC Tien, C Plaisier, ... Neuro-Oncology 21 (Suppl 6), vi236, 2019 | | 2019 |
| STEM-10. MOLECULAR MECHANISMS UNDERLYING PHENOTYPIC PLASTICITY IN MALIGNANT GLIOMA C LoCascio, E Luna-Melendez, S Mehta Neuro-Oncology 20 (Suppl 6), vi245, 2018 | | 2018 |
Nader Sanai, MDDirector of Neurosurgical Oncology, Barrow Neurological InstituteVerified email at bnaneuro.net
